Literature DB >> 29036252

Efficacy of Isotretinoin and Acitretin in Treatment of Frontal Fibrosing Alopecia: Retrospective Analysis of 54 Cases.

Adriana Rakowska, Agnieszka Gradzińska, Małgorzata Olszewska, Lidia Rudnicka.   

Abstract

This study aimed to assess the efficacy of systemic retinoids in treating frontal fibrosing alopecia (FFA). It was based on a retrospective analysis of 54 female patients with FFA treated with: oral isotretinoin at the daily dose of 20 mg (29/54) or acitretin at the daily dose of 20 mg (11/54) or with oral finasteride 5 mg/daily (14/54). The study was conducted between 2007 and 2017. The basic of the study is the measurement of distance between the frontal hairline and the glabellar crease prior to the commencement of treatment and after 6, 12, and 24 months. The treatment with systemic retinoids lasted between 12 and 16 months (the mean duration of treatment was 13.5 months). The primary treatment goal was defined as no further progression of disease after 12 months of treatment, while the secondary treatment goal was defined as no further progression of disease following the discontinuation of systemic retinoids. The primary treatment goal was achieved by 76% (23/29) of patients treated with isotretinoin, 73% (8/11) of patients treated with acitretin, and 43% (6/14) of patients treated with finasteride. The secondary treatment goal was achieved by 72% (21/29) of patients treated with isotretinoin, 73% (8/11) of patients treated with acitretin, and 43% (6/14) of patients treated with finasteride. Thus, the administration of systemic retinoids may be beneficial for the stabilization of frontal hairline in patients with FFA. <p><em>J Drugs Dermatol. 2017;16(10):988-992.</em></p>.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29036252

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  9 in total

Review 1.  [Frontal fibrosing alopecia-update].

Authors:  Ulrike Blume-Peytavi; Kathrin Hillmann; Andria Constantinou; Annika Vogt
Journal:  Hautarzt       Date:  2022-04-08       Impact factor: 0.751

2.  The efficacy of antimalarial drugs in the therapy of selected forms of cicatricial alopecia.

Authors:  Martyna A Zbiciak-Nylec; Ligia Brzezińska-Wcisło; Natalia Salwowska
Journal:  Postepy Dermatol Alergol       Date:  2021-05-22       Impact factor: 1.837

Review 3.  Lichen planopilaris and frontal fibrosing alopecia: review and update of diagnostic and therapeutic features.

Authors:  Carolina Oliveira Costa Fechine; Neusa Yuriko Sakai Valente; Ricardo Romiti
Journal:  An Bras Dermatol       Date:  2022-04-02       Impact factor: 2.113

Review 4.  Frontal Fibrosing Alopecia: A Review.

Authors:  María Librada Porriño-Bustamante; María Antonia Fernández-Pugnaire; Salvador Arias-Santiago
Journal:  J Clin Med       Date:  2021-04-21       Impact factor: 4.241

5.  Clinical-histopathological profile of the frontal fibrosing alopecia: a retrospective study of 16 cases of a university hospital.

Authors:  Pedro Secchin; Danielle Carvalho Quintella; Nathalia Ávila de Oliveira Paula; Luana Cristina da Silva Andrade; Celso Tavares Sodré
Journal:  An Bras Dermatol       Date:  2019-10-17       Impact factor: 1.896

6.  Therapeutic response of facial papules and inflammation in frontal fibrosing alopecia to low-dose oral isotretinoin.

Authors:  Christine T Pham; Anna-Marie Hosking; Surget Cox; Natasha Atanaskova Mesinkovska
Journal:  JAAD Case Rep       Date:  2020-04-30

7.  Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology.

Authors:  Ediléia Bagatin; Caroline Sousa Costa; Marco Alexandre Dias da Rocha; Fabíola Rosa Picosse; Cristhine Souza Leão Kamamoto; Rodrigo Pirmez; Mayra Ianhez; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2020-10-03       Impact factor: 1.896

8.  Trichoscopy-Derived Hairline Recession Equivalent in Monitoring Frontal Fibrosing Alopecia.

Authors:  Justyna Sicińska; Michał Kasprzak; Irena Walecka
Journal:  Skin Appendage Disord       Date:  2022-05-19

9.  Oral isotretinoin for the treatment of dermatologic conditions other than acne: a systematic review and discussion of future directions.

Authors:  Sherman Chu; Lauren Michelle; Chloe Ekelem; Calvin T Sung; Nathan Rojek; Natasha A Mesinkovska
Journal:  Arch Dermatol Res       Date:  2020-11-05       Impact factor: 3.017

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.